Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Antibacterial wound dressing based on advanced nanotechnology to improve the efficiency of wound care

Project description

Nanotechnology-based wound dressing

Infection is a major cause of limb amputation among patients with chronic wounds. Millions of amputations occur annually resulting in extremely high healthcare costs due to the inefficacy of current solutions. Funded by the European Innovation Council, the NANOWOUND project is supporting Estonia-based health tech startup Nanordica Medical in further developing its pioneering antibacterial wound dressing product. The innovation treats bacterial infection eight times better than current solutions and cures wounds that cannot be cured with other methods according to a pilot clinical trial. NANOWOUND aims to contribute towards the development of a range of antibacterial medical devices which will ultimately beat antibiotic resistance.

Objective

Infected wounds are a major cause of limb amputations among patients with chronic diseases like diabetes. 10mln amputations occur annually causing €100bln additional healthcare costs. During COVID-19 pandemic the number of amputations rose 10 fold due to low efficacy of current solutions.
Nanordica develops an advanced Antibacterial Wound Dressing (AWD) to prevent and treat wound infections. We have demonstrated that our AWD removes bacterial infection 8x better than current best. Our value propositions are high efficacy and low cost.
Global antibacterial wound dressing market is projected to reach €4.2bln in 2026 at CAGR 5.7%. Our business model is B2B using distributors to reach our customers, i.e. hospitals. We have a priority for intellectual property and initiated a pilot clinical trial at the largest Estonian hospital.
Our mission is to bring AWD to the market to improve the outcome of wound infections, lower healthcare costs and help hundreds of millions of patients.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2022-ACCELERATOR-01

See all projects funded under this call

Coordinator

NANORDICA MEDICAL OU
Net EU contribution
€ 2 402 750,00
Address
MAEALUSE TN 2/1
12618 TALLINN
Estonia
SME
Yes
Region
Eesti Eesti Põhja-Eesti
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 3 432 500,00